Results 151 to 160 of about 1,270,906 (355)

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Mandatory environmental and human rights due diligence

open access: yesTobacco Induced Diseases, 2021
Danielle van Kalmthout   +4 more
doaj   +1 more source

Preliminary design of an intermittent smoke flow visualization system [PDF]

open access: yes
A prototype intermittent flow visualization system that was designed to study vortex flow field dynamics has been constructed and tested through its ground test phase.
Myatt, James H., Ward, Donald T.
core   +1 more source

Material properties of nanoclay PVC composites [PDF]

open access: yes, 2009
Nanocomposites of poly(vinyl chloride) have been prepared using both hectorite- and bentonite-based organically-modified clays. The organic modification used is tallow-triethanol-ammonium ion.
Awad, Walid   +7 more
core   +1 more source

Evaluating a Pragmatic Strength Alternative for Frailty Measurement and Assessing Its Predictive Capacity Against Established Frailty Instruments in Rheumatoid Arthritis

open access: yesArthritis Care &Research, EarlyView.
Objective Frailty occurs prematurely in rheumatoid arthritis (RA) and is associated with poor health outcomes. We compared the performance of four frailty instruments, including a pragmatic alternative measure using chair sit‐to‐stand (STS), and evaluated their abilities to predict poor health outcomes.
Kylie E. Riggles   +14 more
wiley   +1 more source

Does Cedomon work? [PDF]

open access: yes, 2005
In 2003 there was an experiment in Agrifood Research Finland (Vihti), which compared Cedomon, Baytan, wood smoke treatment and no-treatment.
Lötjönen, Timo, Torniainen, Merja
core  

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

open access: yesArthritis Care &Research, EarlyView.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino   +9 more
wiley   +1 more source

Particulate exhaust emissions from an experimental combustor [PDF]

open access: yes
The concentration of dry particulates (carbon) in the exhaust of an experimental gas turbine combustor was measured at simulated takeoff operating conditions and correlated with the standard smoke-number measurement.
Ingebo, R. D., Norgren, C. T.
core   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns   +2 more
wiley   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy